Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Current Assets:
Cash	$ 23	$ 22,203
Prepaid expenses	80,373	160,750
Other current assets	2,193	12,218
Total Assets	82,589	195,171
Current Liabilities:
Accounts payable	1,882,402	1,467,052
Accrued compensation	973,658	960,554
Derivative liabilities	32,300	33,000
Financing liability	22,033	42,033
Accrued dividend payable	352,205	25,540
Total Liabilities	16,836,732	15,806,714
Commitments and contingencies (Note 8)
Stockholders’ Deficiency:
Common Stock, $0.001 par value, 200,000,000 shares authorized; 41,019,348 and 39,830,802 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively	41,019	39,831
Additional paid-in capital	26,145,630	26,014,028
Accumulated deficit	(42,942,794)	(41,667,388)
Total Stockholders’ Deficiency	(16,754,143)	(15,611,543)
Total Liabilities and Stockholders’ Deficiency	82,589	195,171
Series A Convertible Preferred Stock [Member]
Stockholders’ Deficiency:
Preferred stock, value	1,342	1,342
Series B Convertible Preferred Stock [Member]
Stockholders’ Deficiency:
Preferred stock, value	110	107
Series C Convertible Preferred Stock [Member]
Stockholders’ Deficiency:
Preferred stock, value	550	537
Nonrelated Party [Member]
Current Liabilities:
Accrued expenses	1,321,469	1,225,195
Accrued interest	938,432	939,549
Notes payable	711,093	710,317
Convertible notes payable	982,999	1,078,821
Advances payable	135,000	135,000
Related Party [Member]
Current Liabilities:
Accrued expenses	159,000	144,500
Accrued interest	1,620,097	1,480,117
Notes payable	150,000	150,000
Convertible notes payable	7,456,044	7,315,036
Advances payable	$ 100,000	$ 100,000